441 research outputs found
Wigner Function Description of the A.C.-Transport Through a Two-Dimensional Quantum Point Contact
We have calculated the admittance of a two-dimensional quantum point contact
(QPC) using a novel variant of the Wigner distribution function (WDF)
formalism. In the semiclassical approximation, a Boltzman-like equation is
derived for the partial WDF describing both propagating and nonpropagating
electron modes in an effective potential generated by the adiabatic QPC. We
show that this quantum kinetic approach leads to the well-known stepwise
behavior of the real part of the admittance (the conductance), and of the
imaginary part of the admittance (the emittance), in agreement with the latest
results, which is determined by the number of propagating electron modes. It is
shown, that the emittance is sensitive to the geometry of the QPC, and can be
controlled by the gate voltage. We established that the emittance has
contributions corresponding to both quantum inductance and quantum capacitance.
Stepwise oscillations in the quantum inductance are determined by the harmonic
mean of the velocities for the propagating modes, whereas the quantum
capacitance is a significant mesoscopic manifestation of the non-propagating
(reflecting) modes.Comment: 23 pages (latex), 3 figure
Scanning Tunneling Microscopy currents on locally disordered graphene
We study the local density of states at and around a substituting impurity
and use these results to compute current versus bias characteristic curves of
Scanning Tunneling Microscopy (STM) experiments done on the surface of
graphene. This allow us to detect the presence of substituting impurities on
graphene. The case of vacancies is also analyzed. We find that the shape and
magnitude of the STM characteristic curves depend on the position of the tip
and on the nature of the defect, with the strength of the binging between the
impurity and the carbon atoms playing an important role. Also the nature of the
last atom of the tip has an influence on the shape of the characteristic curve.Comment: Accepted in PR
Lattice Green's function approach to the solution of the spectrum of an array of quantum dots and its linear conductance
In this paper we derive general relations for the band-structure of an array
of quantum dots and compute its transport properties when connected to two
perfect leads. The exact lattice Green's functions for the perfect array and
with an attached adatom are derived. The expressions for the linear conductance
for the perfect array as well as for the array with a defect are presented. The
calculations are illustrated for a dot made of three atoms. The results derived
here are also the starting point to include the effect of electron-electron and
electron-phonon interactions on the transport properties of quantum dot arrays.
Different derivations of the exact lattice Green's functions are discussed
Quantum mechanics of lattice gas automata. I. One particle plane waves and potentials
Classical lattice gas automata effectively simulate physical processes such
as diffusion and fluid flow (in certain parameter regimes) despite their
simplicity at the microscale. Motivated by current interest in quantum
computation we recently defined quantum lattice gas automata; in this paper we
initiate a project to analyze which physical processes these models can
effectively simulate. Studying the single particle sector of a one dimensional
quantum lattice gas we find discrete analogues of plane waves and wave packets,
and then investigate their behaviour in the presence of inhomogeneous
potentials.Comment: 19 pages, plain TeX, 14 PostScript figures included with epsf.tex
(ignore the under/overfull \vbox error messages), two additional large
figures available upon reques
Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression
Sigma-1 and sigma-2 receptors are emerging therapeutic targets. We have identified that simple ammonium salts bind to these receptors and are effective in vivo. Radioligand binding assays were used to obtain structure-activity relationships of these salts. MTS assays were performed to determine their effect on growth in MCF7 and MDA-MB-486 cells. Anticancer properties were tested in NMRI mice transplanted with a fragment of mouse adenocarcinoma (MAC13). Antidepressant activity was tested using the forced-swim test and tailsuspension tests. Dipentylammonium (Ki 43 nM),tripentylammonium (Ki 15 nM) and trihexylammonium (Ki 9 nM) showed high affinity for the sigma-1receptor. Dioctanoylammonium had the highest affinity (K50 0.05 nM); this also showed the highest affinity for sigma-2 receptors (Ki 13 nM). Dipentylammonium was found to have antidepressant activity in vivo. Branched-chain ammonium salts showed lower affinity. Bis(2-ethylhexyl)ammonium (K50 29 ÎŒM), triisopentylammonium (K50 196 ÎŒM) and dioctanoylammonium showed a low Hill slope,and fitted a 2-site binding model for the sigma-1 receptor. We propose this two-site binding can be used to biochemically define a sigma-1 receptor antagonist. Bis(2-ethylhexyl)ammonium and triisopentylammonium were able to inhibit the growth of tumours in vivo. Cheap, simple ammonium salts act as sigma-1 receptor agonists and antagonists in vivo and require further investigation
Troponin-Guided Coronary Computed Tomography Angiography After Exclusion of Myocardial Infarction
Gefitinib and <i>EGFR</i> Gene Copy Number Aberrations in Esophageal Cancer
Purpose: The cancer esophagus gefitinib (COG) trial demonstrated improved progression free survival with the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor (TKI), gefitinib relative to placebo in advanced esophageal cancer patients with disease progression after chemotherapy. Rapid and durable responses were observed in a minority. We hypothesised that genetic aberration of the EGFR pathway would identify patients benefitting from gefitinib.
Patients and Methods: A pre-specified blinded molecular analysis of COG trial tumours was conducted to compare efficacy of gefitinib to placebo according to EGFR copy number gain (CNG) and EGFR, KRAS, BRAF and PIK3CA mutation status. EGFR CNG was determined by fluorescent insitu hybridisation (FISH) using pre-specified criteria and EGFR FISH positive defined as high polysomy or amplification.
Results: Biomarker data were available for 340 patients. In EGFR FISH positive tumours (20.2%) overall survival was improved with gefitinib compared to placebo (hazard ratio [HR] for death, 0.59; 95% confidence interval [CI], 0.35, 1.00 p=0.05). In EGFR FISH negative tumours there was no difference in overall survival with gefitinib compared to placebo (HR for death, 0.90, 95% CI 0.69, 1.18 p=0.46). EGFR amplification (7.2%) patients gained greatest benefit from gefitinib (HR for death, 0.21; 95% CI 0.07-0.64; p=0.006). There was no difference in overall survival for gefitinib versus placebo for patients with EGFR, KRAS, BRAF and PIK3CA mutations, or for any mutation versus none.
Conclusion: EGFR CNG assessed by FISH appears to identify a subgroup of esophageal cancer patients who may benefit from gefitinib as a second line treatment, and suggests that anti-EGFR 3 therapies should be investigated in prospective clinical trials in different settings in EGFR FI SH positive, and in particular EGFR amplified, esophageal cancer
Structural design with Accoya wood
The benefits from acetylation of wood to enhance resistance against fungal decay and dimensional stability have been known for many years. Since 2007 Accsys Technologies has been commercially producing Accoya wood that is based on acetylation of Radiata pine. Accoya has shown its potential for many applications, even for structural use. However, due to limited engineering data each project had to be evaluated on a case-by-case basis. Based on research at various universities and institutes, Accsys Technologies has in combination with TimberSolve and ARUP, developed a handbook to assist designers and structural engineers produce reliable, durable and consistent designs utilising Accoya wood in structural applications
High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome
Background:
Guidelines acknowledge the emerging role of high-sensitivity cardiac troponin (hs-cTnl) for risk stratification and the early rule-out of myocardial infarction, but multiple thresholds have been described. We evaluate the safety and effectiveness of risk stratification thresholds in patients with suspected acute coronary syndrome.
Methods:
Consecutive patients with suspected acute coronary syndrome (n=48â282) were enrolled in a multicenter trial across 10 hospitals in Scotland. In a prespecified secondary and observational analysis, we compared the performance of the limit of detection (<2 ng/L) and an optimized risk stratification threshold (<5 ng/L) using the Abbott high-sensitivity troponin I assay. Patients with myocardial injury at presentation, with â€2 hours of symptoms or with ST-segment elevation myocardial infarction were excluded. The negative predictive value was determined in all patients and in subgroups for a primary outcome of myocardial infarction or cardiac death within 30 days. The secondary outcome was myocardial infarction or cardiac death at 12 months, with risk modeled using logistic regression adjusted for age and sex.
Results:
In total, 32â837 consecutive patients (61±17 years, 47% female) were included, of whom 23â260 (71%) and 12,716 (39%) had hs-cTnl concentrations of <5 ng/L and <2 ng/L at presentation. The negative predictive value for the primary outcome was 99.8% (95% CI, 99.7%â99.8%) and 99.9% (95% CI, 99.8%â99.9%) in those with hs-cTnl concentrations of <5 ng/L and <2 ng/L, respectively. At both thresholds, the negative predictive value was consistent in men and women and across all age groups, although the proportion of patients identified as low risk fell with increasing age. Compared with patients with hs-cTnl concentrations of â„5 ng/L but <99th centile, the risk of myocardial infarction or cardiac death at 12 months was 77% lower in those <5 ng/L (5.3% vs 0.7%; adjusted odds ratio, 0.23 [95% CI, 0.19â0.28]) and 80% lower in those <2 ng/L (5.3% vs 0.3%; adjusted odds ratio, 0.20 [95% CI, 0.14â0.29]).
Conclusions:
Use of risk stratification thresholds for hs-cTnl identify patients with suspected acute coronary syndrome and at least 2 hours of symptoms as low risk at presentation irrespective of age and sex
Influence of age on the diagnosis of myocardial infarction
The 99th centile of cardiac troponin, derived from a healthy reference population, is recommended as the diagnostic threshold for myocardial infarction, but troponin concentrations are strongly influenced by age. Our aim was to assess the diagnostic performance of cardiac troponin in older patients presenting with suspected myocardial infarction. METHODS: In a secondary analysis of a multicenter trial of consecutive patients with suspected myocardial infarction, we assessed the diagnostic accuracy of high-sensitivity cardiac troponin I at presentation for the diagnosis of type 1, type 2, or type 4b myocardial infarction across 3 age groups (<50, 50â74, and â„75 years) using guideline-recommended sex-specific and age-adjusted 99th centile thresholds. RESULTS: In 46â435 consecutive patients aged 18 to 108 years (mean, 61±17 years), 5216 (11%) had a diagnosis of myocardial infarction. In patients <50 (n=12â379), 50 to 74 (n=22â380), and â„75 (n=11â676) years, the sensitivity of the guideline-recommended threshold was similar at 79.2% (95% CI, 75.5â82.9), 80.6% (95% CI, 79.2â82.1), and 81.6% (95% CI, 79.8â83.2), respectively. The specificity decreased with advancing age from 98.3% (95% CI, 98.1â98.5) to 95.5% (95% CI, 95.2â95.8), and 82.6% (95% CI, 81.9â83.4). The use of age-adjusted 99th centile thresholds improved the specificity (91.3% [90.8%â91.9%] versus 82.6% [95% CI, 81.9%â83.4%]) and positive predictive value (59.3% [57.0%â61.5%] versus 51.5% [49.9%â53.3%]) for myocardial infarction in patients â„75 years but failed to prevent the decrease in either parameter with increasing age and resulted in a marked reduction in sensitivity compared with the use of the guideline-recommended threshold (55.9% [53.6%â57.9%] versus 81.6% [79.8%â83.3%]. CONCLUSIONS: Age alters the diagnostic performance of cardiac troponin, with reduced specificity and positive predictive value in older patients when applying the guideline-recommended or age-adjusted 99th centiles. Individualized diagnostic approaches rather than the adjustment of binary thresholds are needed in an aging population
- âŠ